178 filings
Page 2 of 9
8-K
k4w wz6omjwqsaape
30 Sep 22
Regulation FD Disclosure
7:58am
8-K
9z1cxqmk0
21 Sep 22
Intercept Pharmaceuticals Announces Summary of Key Actions in Strategic Financial Repositioning
7:30am
8-K
c5sj78mr
20 Sep 22
Other Events
4:01pm
8-K
4vted98nn6j8hi0xg
12 Sep 22
Entry into a Material Definitive Agreement
7:30am
8-K
ffb89b oosu7
8 Sep 22
Unregistered Sales of Equity Securities
5:00pm
8-K
d9e3fy4
7 Sep 22
Entry into a Material Definitive Agreement
7:30am
8-K
tzaoui2724h26nybhr
6 Sep 22
Unregistered Sales of Equity Securities
5:15pm
8-K
fklnufcqoacngqn64ls3
2 Sep 22
Entry into a Material Definitive Agreement
7:31am
8-K
6nc5vpa voc2nev3w6az
26 Aug 22
Unregistered Sales of Equity Securities
4:01pm
8-K
3174e
19 Aug 22
Intercept Pharmaceuticals Announces Repurchase of Convertible Notes
7:30am
8-K
m7bvlha3r
16 Aug 22
Other Events
4:01pm
8-K
wab97279
3 Aug 22
Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
7:00am
8-K
7exw1w8
26 Jul 22
Other Events
7:30am
8-K
8hdlm3azvmslr51
8 Jul 22
Entry into a Material Definitive Agreement
5:29pm
8-K
07g2z8 bx
7 Jul 22
Regulation FD Disclosure
7:30am
8-K
tn8pgkg
1 Jul 22
Regulation FD Disclosure
4:45pm
8-K
ayt6osnw
21 Jun 22
Other Events
4:02pm
8-K
w59kbhp
6 Jun 22
Intercept Provides Update on NASH Regulatory Timeline
6:30am
8-K
uw6ouo0o
3 Jun 22
Intercept Announces New Clinical Trial and Real-World Outcomes Data
7:45am
8-K
uj3mr4d hsv
2 Jun 22
Departure of Directors or Certain Officers
4:06pm